NSEGeneral Updates2 Jul 2026 · 2 Jul 2026, 09:26 pm
General Updates
Laurus Labs Limited · LAURUSLABS
✦ AI SummaryMgmt Change
Laurus Labs Limited has informed the Exchange about the appointment of two independent directors at its 21st Annual General Meeting.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Laurus Labs Limited has informed the Exchange about Appointment of Independent Directors at the 21st Annual General Meeting of the Company
Attachments (1)
📄pdf
Download →
LAURUSLABS_02072026212212_AGMIDAppointment.pdf
View document text
July 2, 2026
To To
The Corporate Relations Department The Listing Department
BSE Limited National Stock Exchange of India Ltd.,
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra Kurla Complex, Bandra (E),
Mumbai – 400 001 Mumbai – 400 051
Code: 540222 Code: LAURUSLABS
Sub: Appointment of Independent Directors at the 21st Annual General Meeting of the Company
Dear Sir / Madam,
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
(“SEBI Listing Regulations”), and further to intimation dated April 30, 2026, we would like to inform that the
Members of the Company at the 21st Annual General Meeting held today, i.e., on July 2, 2026, inter alia, have
approved the appointment of:
1. Dr. Shekhar Chintamani Mande (DIN: 10083454), as an Independent Director of the Company for a term
of 5 (five) consecutive years with effect from July 2, 2026; and
2. Ms. Sutapa Banerjee (DIN: 02844650), as an Independent Director of the Company for a term of 5 (five)
consecutive years with effect from July 2, 2026.
Dr. Shekhar Chintamani Mande and Ms. Sutapa Banerjee are not related to any of the Directors or Key
Managerial Personnel of the Company and based on their declaration they are not debarred from holding the
office of Director by virtue of any SEBI order or any other such authority.
The relevant details as required under the SEBI Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, has already been submitted vide our
intimation dated April 30, 2026.
This is for your information and record please.
Thanking you.
Yours faithfully,
For Laurus Labs Limited
G. Venkateswar Reddy
Company Secretary & Compliance Officer